Advertisement

Topics

TransEnterix Announces Senhance US Sale Agreement With Florida Hospital

08:45 EST 13 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
First Agreement to Purchase Senhance Surgical System in the US TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced ...

Other Sources for this Article

For TransEnterix, Inc.
Investor Contact:
Mark Klausner, +1 443-213-0501
invest@transenterix.com
or
Media Contact:
Joanna Rice, + 1 951-751-1858
joanna@greymattermarketing.com

NEXT ARTICLE

More From BioPortfolio on "TransEnterix Announces Senhance US Sale Agreement With Florida Hospital"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...